Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes-The TrialNet Experience

Diabetes
Carla J GreenbaumMark A Atkinson

Abstract

The early to mid-1980s were an inflection point in the history of type 1 diabetes research. Two landmark events occurred: the initiation of immune-based interventions seeking to prevent type 1 diabetes and the presentation of an innovative model describing the disorder's natural history. Both formed the basis for hundreds of subsequent studies designed to achieve a dramatic therapeutic goal-a means to prevent and/or reverse type 1 diabetes. However, the need to screen large numbers of individuals and prospectively monitor them using immunologic and metabolic tests for extended periods of time suggested such efforts would require a large collaborative network. Hence, the National Institutes of Health formed the landmark Diabetes Prevention Trial-Type 1 (DPT-1) in the mid-1990s, an effort that led to Type 1 Diabetes TrialNet. TrialNet studies have helped identify novel biomarkers; delineate type 1 diabetes progression, resulting in identification of highly predictable stages defined by the accumulation of autoantibodies (stage 1), dysglycemia (stage 2), and disease meeting clinical criteria for diagnosis (stage 3); and oversee numerous clinical trials aimed at preventing disease progression. Such efforts pave the way for stage-sp...Continue Reading

References

May 22, 1986·The New England Journal of Medicine·G S Eisenbarth
Jan 10, 2003·The Journal of Clinical Endocrinology and Metabolism·Jeffrey P KrischerGeorge S Eisenbarth
Aug 5, 2004·The Journal of Clinical Endocrinology and Metabolism·Jennifer M BarkerUNKNOWN Diabetes Autoimmunity Study in the Young
Feb 9, 2006·The Journal of Clinical Endocrinology and Metabolism·Maria J RedondoUNKNOWN Diabetes Prevention Trial Type 1 Study Group
Jan 6, 2009·Annals of the New York Academy of Sciences·UNKNOWN TEDDY Study Group
Jan 6, 2009·Annals of the New York Academy of Sciences·Jay S SkylerUNKNOWN Type 1 Diabetes TrialNet Study Group
May 1, 2010·Nature·Jeffrey A BluestoneGeorge Eisenbarth
Aug 5, 2010·Diabetes·Jay M SosenkoUNKNOWN Diabetes Prevention Trial-Type 1 Study Group
Apr 14, 2011·Diabetes/metabolism Research and Reviews·Carla J GreenbaumUNKNOWN Diabetes Prevention Trial, Type 1 Diabetes (DPT-1) Study Group
Apr 29, 2011·Diabetes·Mark A AtkinsonChristopher J Rhodes
Jun 3, 2011·The American Journal of Clinical Nutrition·Sandra Hummel, Anette G Ziegler
Jul 14, 2011·Diabetes Care·Kendra VehikUNKNOWN TrialNet Natural History Study Group
Jul 22, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kevan C HeroldUNKNOWN Type 1 Diabetes TrialNet Anti-CD20 Study Group
Aug 2, 2011·The Journal of Clinical Investigation·Laurence MenardEric Meffre
Aug 13, 2011·Diabetes·Liping YuUNKNOWN Type 1 Diabetes TrialNet Anti-CD20 Study Group
Sep 13, 2011·The Journal of Allergy and Clinical Immunology·Mark D PescovitzUNKNOWN Type 1 Diabetes TrialNet Study Group
Nov 23, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tania HabibJane H Buckner
Feb 1, 2012·Diabetologia·A-G ZieglerUNKNOWN BABYDIAB-BABYDIET Study Group
Oct 4, 2012·Diabetes Care·Anna ParkkolaUNKNOWN Finnish Pediatric Diabetes Register
Jun 20, 2013·JAMA : the Journal of the American Medical Association·Anette G ZieglerGeorge S Eisenbarth
Jul 31, 2013·Lancet·Mark A AtkinsonAaron W Michels
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Jul 9, 2014·Endocrinology·Sahar Usmani-BrownMichel Ledizet
Dec 17, 2014·The Journal of Clinical Investigation·Michael J HallerDesmond A Schatz
Dec 19, 2014·Diabetes Care·Asa K DavisUNKNOWN T1D Exchange Clinic Network
Feb 3, 2015·The Journal of Clinical Investigation·Kevan C HeroldUNKNOWN Type 1 Diabetes TrialNet Study Group
May 23, 2015·Pediatric Diabetes·Martha Campbell-Thompson
Jun 19, 2015·Current Opinion in Endocrinology, Diabetes, and Obesity·John S KaddisMark A Atkinson
Jul 4, 2015·Diabetologia·Eleni Z GiannopoulouAnette-G Ziegler
Nov 20, 2015·Diabetes·Martha Campbell-ThompsonMark A Atkinson

❮ Previous
Next ❯

Citations

Mar 5, 2019·JCI Insight·Peter S LinsleyMatthew J Dufort
Mar 25, 2020·Current Opinion in Rheumatology·H Karl GreenblattKevin D Deane
May 14, 2020·Nature Reviews. Endocrinology·Décio L EizirikMiriam Cnop
Jul 2, 2020·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Anne JörnsSigurd Lenzen
Jul 4, 2020·Current Opinion in Endocrinology, Diabetes, and Obesity·Emily K SimsCarmella Evans-Molina
Jul 1, 2020·Arthritis & Rheumatology·Kevin D Deane, V Michael Holers
Jan 24, 2021·Immunology and Cell Biology·Alice E WiedemanSarah Alice Long
Mar 5, 2021·Science Translational Medicine·Emily K SimsUNKNOWN Type 1 Diabetes TrialNet Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

© 2022 Meta ULC. All rights reserved